NCT00545844View on ClinicalTrials.gov

Singulair(R) In Asthma And Allergic Rhinitis (0476-383)

PHASE4CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

April 1, 2007

Primary Completion Date

January 1, 2008

Study Completion Date

January 1, 2008

Conditions
Asthma
Interventions
DRUG

montelukast sodium

montelukast sodium, 10 mg, one tablet once a day for 8 weeks as add on therapy to usual current asthma controller treatment

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00545844 - Singulair(R) In Asthma And Allergic Rhinitis (0476-383) | Biotech Hunter | Biotech Hunter